Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥4.9t

Manufactures and sells pharmaceutical products in Japan and internationally.

GNI Group

Market Cap: JP¥186.2b

Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.

PeptiDream

Market Cap: JP¥134.1b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Nxera Pharma

Market Cap: JP¥88.4b

Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.

SanBio

Market Cap: JP¥79.9b

Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.

Heartseed

Market Cap: JP¥37.5b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Healios K.K

Market Cap: JP¥32.5b

Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

StemRIM

Market Cap: JP¥19.4b

A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.

Kidswell Bio

Market Cap: JP¥7.4b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

Noile-Immune Biotech

Market Cap: JP¥5.5b

Researches and develops CAR-T cells for novel cancer immunotherapies.

TMS

Market Cap: JP¥4.7b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.